These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26965912)

  • 1. The degree of urinary hypercortisolism is not correlated with the severity of cushing's syndrome.
    Guarnotta V; Amato MC; Pivonello R; Arnaldi G; Ciresi A; Trementino L; Citarrella R; Iacuaniello D; Michetti G; Simeoli C; Colao A; Giordano C
    Endocrine; 2017 Feb; 55(2):564-572. PubMed ID: 26965912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cushing's Syndrome: Screening and Diagnosis.
    Ceccato F; Boscaro M
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):209-15. PubMed ID: 27160717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late-night salivary cortisol has a better performance than urinary free cortisol in the diagnosis of Cushing's syndrome.
    Elias PC; Martinez EZ; Barone BF; Mermejo LM; Castro M; Moreira AC
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2045-51. PubMed ID: 24628557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of salivary cortisol in the diagnosis of hypercortisolism: comparison with serum and urinary cortisol.
    Manetti L; Rossi G; Grasso L; Raffaelli V; Scattina I; Del Sarto S; Cosottini M; Iannelli A; Gasperi M; Bogazzi F; Martino E
    Eur J Endocrinol; 2013 Mar; 168(3):315-21. PubMed ID: 23211575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening Tests for Cushing's Syndrome: Urinary Free Cortisol Role Measured by LC-MS/MS.
    Ceccato F; Barbot M; Zilio M; Frigo AC; Albiger N; Camozzi V; Antonelli G; Plebani M; Mantero F; Boscaro M; Scaroni C
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3856-61. PubMed ID: 26274344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of normal tests assessing hypercortisolism in subjects with mild and episodic Cushing's syndrome suggests that the paradigm for diagnosis and exclusion of Cushing's syndrome requires multiple testing.
    Friedman TC; Ghods DE; Shahinian HK; Zachery L; Shayesteh N; Seasholtz S; Zuckerbraun E; Lee ML; McCutcheon IE
    Horm Metab Res; 2010 Nov; 42(12):874-81. PubMed ID: 20803415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An accurate, non-invasive approach to diagnose Cushing's syndrome in at-risk populations.
    Cardoso EM; Arregger AL; Monardes G; Contreras LN
    Steroids; 2013 May; 78(5):476-82. PubMed ID: 23485687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Cushing's syndrome in patients with significant hypercortisoluria.
    Hirsch D; Tsvetov G; Manisterski Y; Aviran-Barak N; Nadler V; Alboim S; Kopel V
    Eur J Endocrinol; 2017 Jan; 176(1):41-48. PubMed ID: 27737902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation.
    Ceccato F; Artusi C; Barbot M; Lizzul L; Pinelli S; Costantini G; Niero S; Antonelli G; Plebani M; Scaroni C
    J Endocrinol Invest; 2020 Aug; 43(8):1105-1113. PubMed ID: 32060745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome.
    Kidambi S; Raff H; Findling JW
    Eur J Endocrinol; 2007 Dec; 157(6):725-31. PubMed ID: 18057379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overnight 1 mg dexamethasone suppression test and 24 h urine free cortisol-accuracy and pitfalls when screening for Cushing's syndrome.
    Petersenn S
    Pituitary; 2022 Oct; 25(5):693-697. PubMed ID: 35821308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing's syndrome.
    Putignano P; Toja P; Dubini A; Pecori Giraldi F; Corsello SM; Cavagnini F
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4153-7. PubMed ID: 12970280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late-night salivary cortisol as a screening test for Cushing's syndrome.
    Raff H; Raff JL; Findling JW
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2681-6. PubMed ID: 9709931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 10:00-11:00 pm urine cortisol/creatinine ratio. An alternative to late-night salivary cortisol for the diagnosis of Cushing's syndrome.
    Bruno OD; Rossi MA; Juárez-Allen L; Serra HA; Albiero MC
    Medicina (B Aires); 2015; 75(6):373-8. PubMed ID: 26707659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing's syndrome.
    Reimondo G; Allasino B; Bovio S; Paccotti P; Angeli A; Terzolo M
    Eur J Endocrinol; 2005 Dec; 153(6):803-9. PubMed ID: 16322385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome.
    Findling JW; Raff H; Aron DC
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1222-6. PubMed ID: 15001614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 4-mg intravenous dexamethasone suppression test in the diagnosis of Cushing's syndrome.
    Jung C; Alford FP; Topliss DJ; Burgess JR; Long F; Gome JJ; Stockigt JR; Inder WJ
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):78-84. PubMed ID: 20039897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism.
    Friedman TC
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):356-60. PubMed ID: 16915537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.